ARCT
NASDAQ · Biotechnology
Arcturus Therapeutics Holdin
$8.31
-0.05 (-0.60%)
Open$9.66
Previous Close$8.36
Day High$9.78
Day Low$8.27
52W High$17.96
52W Low$5.50
Volume—
Avg Volume791.0K
Market Cap242.25M
P/E Ratio—
EPS$-3.31
SectorBiotechnology
Analyst Ratings
Strong Buy
19 analysts
Price Target
+217.8% upside
Current
$8.31
$8.31
Target
$26.41
$26.41
$16.23
$26.41 avg
$33.18
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 77.94M | 105.94M | 31.39M |
| Net Income | -62,504,453 | -76,463,242 | -5,088,256 |
| Profit Margin | -80.2% | -76.2% | -16.2% |
| EBITDA | -69,584,700 | -89,853,833 | -7,015,778 |
| Free Cash Flow | — | — | -5,929,972 |
| Rev Growth | -26.4% | -26.4% | +5.3% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.55 | -0.16% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $456.60 | -1.24% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $169.42 | +1.10% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $531.97 | -1.08% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $951.08 | -0.14% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $159.73 | -3.22% | 7.7 | 20.98B |